NSB
WST icon

Norway Savings Bank’s West Pharmaceutical WST Stock Holding History

Norway Savings Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-140
Closed -$50K – 335
2021
Q2 		$50K Hold
140
– – 0.02% 207
2021
Q1 		$39K Sell
140
-9
-6% -$2.58K 0.02% 215
2020
Q4 		$42K Buy
149
+9
+6% +$2.53K 0.02% 204
2020
Q3 		$38K Buy
+140
New +$37K 0.03% 192

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norway Savings Bank's WST Position: Q3 2021 in Review

Norway Savings Bank sold out of West Pharmaceutical (WST) in Q3 2021, closing a stake of 140 shares — an estimated $50K sold.

Norway Savings Bank first reported a position in WST in Q3 2020 and held it in 4 quarters. The position peaked at $50K in Q2 2021. 670 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • Norway Savings Bank reported no remaining West Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Norway Savings Bank sold 140 West Pharmaceutical shares in Q3 2021, an estimated $50K.
  • Norway Savings Bank first reported a position in West Pharmaceutical in Q3 2020 and held it in 4 quarters.
  • Norway Savings Bank's West Pharmaceutical position peaked at $50K in Q2 2021.
  • 670 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on Norway Savings Bank's 13F filing for Q3 2021, filed 14 Oct 2021.